CD4 and in situ carcinoma: In adenocarcinoma samples, the most abundant immune cells were resting memory CD4+ T cells (21%) followed by M0 macrophages (14%), regulatory T cells (8%) and activated memory CD4+ T cells (7%) compared to adenoma and CIS as observed previously [37,38,39,40].